Rachael Easton
Director of Finance/CFO chez GLADSTONE INVESTMENT CORPORATION
Profil
Rachael Easton is currently the Chief Financial Officer & Treasurer at Gladstone Investment Corp.
and the Vice President & Head-Clinical Development at Cogent Biosciences, Inc. She previously worked as the Sr. Medical Director-Oncology Clinical Development at GSK Plc.
Easton received her undergraduate degree from Washington & Lee University and her doctorate from Washington University School of Medicine.
Postes actifs de Rachael Easton
| Sociétés | Poste | Début |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 28/11/2022 |
| GLADSTONE INVESTMENT CORPORATION | Director of Finance/CFO | 01/12/2021 |
Anciens postes connus de Rachael Easton
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Formation de Rachael Easton
| Washington & Lee University | Undergraduate Degree |
| Washington University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gladstone Investment Corp.
 Gladstone Investment Corp. Investment ManagersFinance Gladstone Investment Corp., a traded business development company invests in lower middle market companies located in the United States. The fund focuses on companies with an EBITDA of $3 to $20 million. It targets companies operating in the fields of manufacturing, consumer products and business and consumer services. It provides financing for debt, buyout and growth stage capital requirements with an investment size up to $75 million.. | Finance |
